TT&A, A&O Shearman Advise on Anthem Biosciences ₹250 Cr Share Sale

• Portsmouth Technologies, LLC completed a secondary sale of 3,000,000 Anthem Biosciences Limited equity shares.
• The transaction amounted to approximately ₹250 crore and occurred on the BSE and NSE trading platforms.
• J.P. Morgan India Private Limited acted as the broker for the share sale.
• TT&A provided Indian legal counsel to J.P. Morgan India, with Abhinav Kumar and Indira Satish on the team.
• A&O Shearman served as international legal counsel for J.P. Morgan India during the transaction.

For lawyers advising brokers on similar transactions, this case illustrates the collaborative efforts and specific legal guidance necessary to successfully execute such high-value secondary share sales.

Portsmouth Technologies, LLC recently executed a significant secondary share sale involving Anthem Biosciences Limited. This transaction saw Portsmouth Technologies divest 3,000,000 equity shares of Anthem Biosciences, generating approximately ₹250 crore. The sale was facilitated through the screen-based trading platforms of both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India.

This substantial secondary share sale on Indian stock exchanges highlights the continued activity in the country's capital markets. The shares, belonging to Anthem Biosciences Limited, were offloaded by Portsmouth Technologies, LLC, marking a notable event for both entities and the broader market.

J.P. Morgan India Private Limited served as the broker for this considerable share sale. Providing crucial legal counsel to J.P. Morgan India for the domestic aspects of the transaction was the firm TT&A. The TT&A team advising on this engagement included Partner Abhinav Kumar and Senior Associate Indira Satish, who were instrumental in guiding the broker through the process.

Further reinforcing the legal framework for the deal, A&O Shearman acted as the international legal counsel for J.P. Morgan India. The involvement of these prominent legal firms underscores the complexity and importance of such a large-scale secondary share sale, particularly one executed across major Indian trading platforms.

This ₹250 crore share sale in India, specifically a secondary share sale on the BSE and NSE, provides a valuable precedent for legal practitioners. The transaction showcases the intricate coordination required when advising brokers on significant capital markets deals, particularly those involving international sellers like Portsmouth Technologies and Indian listed entities such as Anthem Biosciences.

The engagement of TT&A and A&O Shearman as legal counsel for J.P. Morgan India in this deal further emphasizes the specialized expertise demanded in navigating the regulatory and operational landscape of large-scale equity divestments. For lawyers advising brokers on similar transactions, this case illustrates the collaborative efforts and specific legal guidance necessary to successfully execute such high-value secondary share sales.

This transaction provides a precedent for lawyers advising brokers on large secondary share sales on Indian stock exchanges, highlighting the involvement of TT&A and A&O Shearman in such significant capital markets deals.

Source: Original reporting via Bar & Bench